Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Commense signs licensing agreement with UBC for microbiome-based therapy to prevent asthma

May 5, 2017

MDxHealth and Maastricht University expand research collaboration

May 5, 2017

Saniona participates in formation of Scandion Oncology

May 5, 2017

NIH grant supports Spero's preclinical development of SPR-720 for TB

May 5, 2017

Heat Biologics completes acquisition of Pelican Therapeutics

May 4, 2017

Novartis exercises license option for emricasan

May 4, 2017

Servier and Miragen extend cardiovascular collaboration

May 4, 2017

ImmunGene regains rights to three antibody-interferon fusion product candidates

May 4, 2017

Selecta licenses LMB-100 from National Cancer Institute

May 3, 2017

NIAID grant supports Lyndra's development of ultra-long acting HIV therapy

May 3, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...